Published in Aliment Pharmacol Ther on February 15, 2009
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology (2011) 1.33
Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C. World J Gastroenterol (2010) 0.89
Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients. PLoS One (2013) 0.89
Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma. Hepat Mon (2013) 0.88
Clinical outcomes of compensated and decompensated cirrhosis: A long term study. World J Hepatol (2014) 0.80
Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma. World J Hepatol (2015) 0.79
Individualization of chronic hepatitis C treatment according to the host characteristics. World J Gastroenterol (2014) 0.78
Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports. Cases J (2009) 0.75
Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study. Hippokratia (2014) 0.75
Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China. Int J Clin Exp Med (2015) 0.75
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology (2001) 5.80
Methodological issues in studies of air pollution and daily counts of deaths or hospital admissions. J Epidemiol Community Health (1996) 4.44
Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health (1996) 3.90
Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med (2001) 3.40
Evidence for interaction between air pollution and high temperature in the causation of excess mortality. Arch Environ Health (1993) 2.67
Time-series analysis of air pollution and cause-specific mortality. Epidemiology (1998) 2.60
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J (1997) 2.43
Urban air pollution and emergency admissions for asthma in four European cities: the APHEA Project. Thorax (1997) 2.31
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall. Tech Coloproctol (2014) 2.15
Short-term effects of nitrogen dioxide on mortality: an analysis within the APHEA project. Eur Respir J (2006) 2.00
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology (2000) 1.66
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Air Pollution and Health: a European Approach. Arch Environ Health (1998) 1.59
BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy. Eur J Neurol (2011) 1.45
Two 46,XX,t(X;Y) females with linear skin defects and congenital microphthalmia: a new syndrome at Xp22.3. J Med Genet (1990) 1.42
Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus. J Hepatol (1994) 1.40
Attitudes of a Mediterranean population to the truth-telling issue. J Med Ethics (1992) 1.39
The 1987 Athens heatwave. Lancet (1988) 1.39
Air pollution and cause specific mortality in Athens. J Epidemiol Community Health (1990) 1.38
A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction (1998) 1.30
Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol (1999) 1.16
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost (2004) 1.14
The temporal pattern of mortality responses to ambient ozone in the APHEA project. J Epidemiol Community Health (2009) 1.13
Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet (2000) 1.13
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM (2000) 1.12
Short-term effects of ambient particles on mortality in the elderly: results from 28 cities in the APHEA2 project. Eur Respir J Suppl (2003) 1.12
Outcome of the distal ureteric stump after (hemi)nephrectomy and subtotal ureterectomy for reflux or obstruction. BJU Int (2001) 1.11
Investigating the dose-response relation between air pollution and total mortality in the APHEA-2 multicity project. Occup Environ Med (2003) 1.10
Investigating regional differences in short-term effects of air pollution on daily mortality in the APHEA project: a sensitivity analysis for controlling long-term trends and seasonality. Environ Health Perspect (2001) 1.10
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report. Haemophilia (2010) 1.09
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat (2006) 1.08
Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care (1998) 1.08
Effects of lead on the somatic growth of children. Arch Environ Health (1998) 1.06
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia (2009) 1.05
Desmoid tumor presenting as intra-abdominal abscess. Dig Dis Sci (2006) 1.04
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis (2010) 1.03
Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen. Immunol Rev (1998) 1.03
Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation. Am J Cardiol (1990) 1.02
Polygenic inherited predisposition to breast cancer. Cold Spring Harb Symp Quant Biol (2005) 1.02
Selective arterial embolization in the management of symptomatic renal angiomyolipomas. Eur J Radiol (1999) 1.02
Intratesticular arteriovenous malformation. Clinical course, ultrasound and MRI findings of an extremely rare lesion on a 7 year follow-up basis. Int Urol Nephrol (2006) 1.02
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. Haemophilia (2007) 1.02
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. Am J Transplant (2012) 1.02
Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. Aliment Pharmacol Ther (2011) 1.01
Male breast myofibroblastoma and MR findings. J Comput Assist Tomogr (1999) 1.00
Epidemiology of haemophilia in Greece: an overview. Thromb Haemost (1994) 0.99
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat (2005) 0.98
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression. Ann Oncol (2011) 0.98
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol (1995) 0.98
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol (2001) 0.96
The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients. J Viral Hepat (2005) 0.96
Review article: novel therapeutic options for chronic hepatitis C. Aliment Pharmacol Ther (2008) 0.96
Molecular phylogeny and biogeography of the wall-lizard Podarcis erhardii (Squamata: Lacertidae). Mol Phylogenet Evol (2003) 0.96
The interaction of criterion and feedback information in learning a drawing task. J Mot Behav (1990) 0.95
Searching for West Nile virus (WNV) in Greece. Transfus Med (2009) 0.95
Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study. J Viral Hepat (2008) 0.94
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat (2010) 0.94
Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. J Viral Hepat (2004) 0.94
Focal nodular hyperplasia: imaging findings. Eur Radiol (2001) 0.94
Imaging and localization of pancreatic insulinomas. Clin Imaging (2001) 0.92
Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Virol Methods (2001) 0.90
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1999) 0.90
Reliability of minute ventilation as a parameter for rate responsive pacing. Pacing Clin Electrophysiol (1989) 0.90
Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med (2000) 0.89
MRI and ultrasonographic findings in the investigation of lymphedema and lipedema. Int Surg (1998) 0.89
HBcAg and HBsAg expression in ductular cells in chronic hepatitis B. Liver (1994) 0.88
Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study. Hippokratia (2011) 0.88
Information sources and level of knowledge of contraception issues among Greek women and men in the reproductive age: a country-wide survey. Eur J Contracept Reprod Health Care (2004) 0.88
Misuse of verapamil in pre-excited atrial fibrillation. Lancet (1989) 0.88
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2007) 0.87
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence". Cancer Metastasis Rev (2013) 0.86
Superselective microcoil embolization of a traumatic pseudoaneurysm of the cavernosal artery. Urol Int (2000) 0.85
Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study. Int J Cancer (1996) 0.84
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort. J Viral Hepat (2014) 0.84
Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig Liver Dis (2007) 0.84
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia (2011) 0.83
Terbinafine-induced cholestatic liver disease. J Hepatol (1996) 0.83
DNA microarrays for identifying fishes. Mar Biotechnol (NY) (2008) 0.83
A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B. Aliment Pharmacol Ther (2006) 0.83
The Bcl-2/Bax system and apoptosis in ulcerative colitis. Hepatogastroenterology (2007) 0.83
Factors associated with severity and disease progression in chronic hepatitis C. Hepatogastroenterology (1999) 0.83
Seasonal variation in exacerbations of ulcerative colitis. Hepatogastroenterology (1997) 0.83
Histopathology of chronic hepatitis C in relation to epidemiological factors. J Hepatol (1996) 0.83
Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.82
Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Vox Sang (2007) 0.82
Hepatic epithelioid hemangioendothelioma: MR imaging findings. Hepatogastroenterology (2001) 0.81